Benzinga report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
Why RDGT Stock dropped -3.32% Today — RQD Quant Desk Flash
Ridgetech Inc. (RDGT) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is RDGT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Ridgetech Inc. (NASDAQ: RDGT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $0.80 (-3.32% 1D, market cap $3.0M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 146 tracked Consumer Staples issuers, RDGT ranks #113 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does RDGT compare to PETS and YI in the Consumer Staples sector?
▼
Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), RDGT carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 3.6%, and ROIC of —. By comparison, PETS (PetMed Express Inc.) holds a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.6M) and YI (111 Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -20.5%, cap $26.2M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for RDGT?
▼
Per RDGT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001856084), Ridgetech Inc. generated $132.2M in revenue (+10.2% YoY), -$1.3M in net income, and -$1.4M in free cash flow against $61.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 3.6% Gross Margin
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 1/9
Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a RDGT Turnaround Squeeze
While RDGT currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Consumer Staples with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.88) and Max Pain ($0.84) forces dealer call-delta covering toward $798.52.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why RDGT Stock dropped -3.32% Today — RQD Quant Desk Flash
Ridgetech Inc. (RDGT) dropped -3.32% to $0.80, trading at 2% of its 52-week range ($0.67 – $760.5). Stretched risk/reward at current multiples (4% profit margin) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.67 – $760.5) with RSI-14 at 47 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.80 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 3.6% gross margin and $0 annual free cash flow.
www.siam.in report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
www.dars.gov.et report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that its wholly owned offline pharmaceutical wholesale dist
Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-15
Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2
Gainers Edible Garden (NASDAQ:EDBL) stock moved upwards by 46.2% to $0.55 during Wednesday's after-market session. The company's market cap stands at $1.8 million. Grocery Outlet Holding (NASDAQ:GO) stock rose 19.99% to
Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its dual-engine growth strategy for 2026. The strategy cent
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring RDGT)
- ✓Walkthrough of RDGT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RDGT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +10.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on RDGT today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for RDGT. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (RDGT)
1. Head-to-Head Consumer Staples Peer Comparison (RDGT vs. PETS, YI, GRDN, CVS)
Industry: Retail-Drug Stores and Proprietary Stores (5 Tracked Issuers)Across 146 tracked Consumer Staples securities in the Roarable RQD universe, Ridgetech Inc. (RDGT) ranks #113 by composite RQD confidence (37/100, grade D-) and #140 by equity capitalization ($3.0M). Within this direct 5-issuer industry benchmark cohort, GRDN leads on earnings valuation at 52.1x trailing P/E, while GRDN leads on capital efficiency and profitability with 37.7% ROIC and 20.2% gross margin. GRDN currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with RDGT at 37/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| RDGT
ACTIVE
Ridgetech Inc. | D- | 37/100 | — | 3.6% | — | -3.32% | $3.0M | Benchmark Subject |
| PETS PetMed Express Inc. | E | 19/100 | — | 28.1% | -35.0% | +0.85% | $25.6M | /pets-vs-rdgt → |
| YI 111 Inc. | D- | 37/100 | — | 5.8% | -20.5% | -4.36% | $26.2M | /yi-vs-rdgt → |
| GRDN Guardian Pharmacy Services Inc. (Class A) | B- | 71/100 | 52.1x | 20.2% | 37.7% | +0.59% | $2.56B | /grdn-vs-rdgt → |
| CVS CVS Health Corporation | C- | 61/100 | 65.3x | 45.0% | 2.6% | -0.09% | $115.53B | /cvs-vs-rdgt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001856084In its most recent audited fiscal period (FY2025, filed 2026-03-31), Ridgetech Inc. (RDGT) reported GAAP revenue of $132.2M (+10.2% vs. FY2024 revenue of $120.0M , and +6.6% cumulative change since FY2023) , GAAP net income of -$1.3M, operating cash flow of -$1.4M, and free cash flow of -$1.4M (-227.6% YoY). On the balance sheet, RDGT closed FY2025 with $61.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-03-31 | $132.2M | -$1.3M | -$1.4M | -$1.4M | $61.4M | — |
| FY2024 (FY) | 2025-03-31 | $120.0M | $10.2M | $1.2M | $1.1M | — | — |
| FY2023 (FY) | 2024-03-31 | $124.0M | -$4.2M | -$3.2M | -$3.2M | — | — |
3. RDGT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs RDGT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Ridgetech Inc. (NASDAQ: RDGT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $0.80 (-3.32% 1D, market cap $3.0M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 146 tracked Consumer Staples issuers, RDGT ranks #113 in composite RQD confidence.
How does RDGT compare to PETS and YI in the Consumer Staples sector?
Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), RDGT carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 3.6%, and ROIC of —. By comparison, PETS (PetMed Express Inc.) holds a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.6M) and YI (111 Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -20.5%, cap $26.2M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for RDGT?
Per RDGT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001856084), Ridgetech Inc. generated $132.2M in revenue (+10.2% YoY), -$1.3M in net income, and -$1.4M in free cash flow against $61.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is RDGT trading relative to its 50-day, 200-day, and 52-week technical levels?
RDGT last traded at $0.80 (-3.32% on volume of 15,405 shares), positioning the stock -9.09% below its 50-day simple moving average ($0.88) and -98.79% below its 200-day simple moving average ($66.13). Across its 52-week range of $0.67 to $760.50, RDGT sits at the 0.0% percentile with a 14-day RSI of 47.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.90).
RDGT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is RDGT stock moving today?
Why RDGT Stock dropped -3.32% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (4% profit margin) under elevated 10-year interest-rate pressure.
RDGT — Ridgetech Inc.: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, RDGT carries an RQD score of 37 and a letter grade of D-, with the verdict "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are scored as follows:
- Fundamental Cash Engine: 10 / 20. The rating reports ROIC of 0% and FCF yield of 0%. For an investor, this means the business is not currently generating a measurable return on invested capital or free cash relative to its valuation, which removes a core source of intrinsic support.
- Whale 13F Flow: 7 / 20. The pillar covers institutional accumulation and options positioning. The score is below midpoint, indicating limited evidence of institutional conviction in the source data.
- Insider Conviction: 5 / 20. This pillar combines SEC Form 4 and Congressional PTR cluster flow. It is the lowest-scoring pillar, which signals weak insider-level confidence in the name.
- Macro Regime Fit: 7 / 20. The rating reports beta of 1.0 and notes sector sensitivity. The stock is assessed as moving in line with the market, without a defensive or macro-tailwind profile that would help it in changing regimes.
- Forensic Balance Sheet: 8 / 20. Per the rating, Altman Z is 2.5, Piotroski F is 1/9, and Debt/Equity is 0.5. The weak Piotroski reading is the key concern: it points to deteriorating financial quality across multiple checks.
Investor implications: The upside case rests almost entirely on a turnaround in cash generation, since current returns and cash yield are zero and institutional and insider flow are weak. Valuation tradeoffs are difficult to assess because P/E and EV/EBITDA are not available in source data, and the market cap of $3.0M against a $0.83 price leaves little margin for error. Investors should treat the rating as a signal of elevated fragility rather than a stable compounding profile.
Business
Ridgetech Inc. is a NASDAQ-listed issuer classified in the Consumer Staples sector, within the Retail-Drug Stores and Proprietary Stores industry. Per the profile, the company's market capitalization is $0.0B. The source data does not describe specific products, customer segments, or revenue model beyond the sector and industry classification.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $132.2M | $-1.9M | $-1.3M | N/A | $-1.4M | N/A | N/A |
| FY 2024 | $120.0M | $-1.0M | $10.2M | N/A | $1.1M | N/A | N/A |
| FY 2023 | $124.0M | $0.6M | $-4.2M | N/A | $-3.2M | N/A | N/A |
Per the market data, gross margin is 3.6%, operating margin is -1.4%, and net margin is -0.9%, with ROIC at 0%. The rating reports an Altman Z-Score of 2.5, a Piotroski F-Score of 1/9, and Debt/Equity of 0.5. Operating income was negative in FY 2025 and FY 2024 and positive in FY 2023, while free cash flow was negative in FY 2025 and FY 2023. The balance sheet posture is characterized by the rating as vulnerable, with cash and debt balances not available in source data.
Recent Catalysts & News Wire Analysis
Per the recent news feed, the wire contains five items tied to RDGT. Items are labeled by light and impact tag as reported:
- Market wire (YELLOW): A report on the stock's after-market session movement among Consumer Staples names.
- Market wire (YELLOW): A report that shares rose 2.82% to $0.87, with the headline referencing an ascending triangle pattern.
- Risk watch (RED): A report that the stock dropped 10.63% on the day referenced, with a headline citing critical support levels.
- Catalyst (GREEN): A report that the stock slipped 3.32% to $0.80, sitting between $0.76 support and $0.84 resistance.
- Catalyst (GREEN): A report on a historical Q3 earnings headline describing a share rise despite an EPS miss.
Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals. The news wire is therefore the only catalyst source, and its items are largely price-action commentary rather than fundamental developments. The headlines are mixed, with one red risk-watch item and two green catalyst items.
Open Questions
- What are the company's cash and debt balances, which are reported as N/A across all periods?
- Why did net income in FY 2024 ($10.2M) diverge sharply from operating income (-$1.0M), and what drove the difference?
- What explains the 52-week range of $0.67 to $760.5, and is the upper bound a data artifact or a real price history?
- What are the trailing and forward earnings and EV/EBITDA multiples needed to assess valuation?
- Who are the institutional and insider holders, given that holder data is not available in source data?
RDGT Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Ridgetech Inc. (RDGT) • Click "Debate This Headline" to argue it in the Roar Pit below
Benzinga report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
www.siam.in report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
www.dars.gov.et report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Ridgetech Inc. (RDGT) market action, institutional positioning, and fundamental catalysts.
Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that its wholly owned offline pharmaceutical wholesale dist
Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-15
Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2
RDGT Bull vs. Bear Conversation Board — What's Your Call at $0.80?
🔥 Official Bull vs. Bear Debate: Is RDGT (D- • RQD 37/100) a Buy at $0.83?
Welcome to the RDGT (Ridgetech Inc.) Roar Pit. Current RQD Composite is 37/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Retail-Drug Stores and Proprietary Stores. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on RDGT — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on RDGT, but look at what you are paying: current EV/EBITDA multiples with 3.6% gross margins. Unless Ridgetech Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
RDGT cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on RDGT, the market is fixating on short-term headline noise in Retail-Drug Stores and Proprietary Stores and ignoring the balance sheet and cash flow trajectory. At $0.83 (52-wk range $0.67 - $760.50), any beat on forward guidance forces shorts and underweight funds to chase.